
Kimberly-Clark Corporation
- Jurisdiction
United States - LEI
MP3J6QPYPGN75NVW2S34 - ISIN
US4943681035 (KMB )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€88.13 16.6% overvalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. Read full profile
Fundamentals
- Net revenue
€16.11B - Gross margin
35.2% - EBIT
€2.61B - EBIT margin
16.2% - Net income
€2.07B - Net margin
12.9%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
- Last dividend amount
-
$1.26 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
67.6%
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Hicks Zackery A | Chief Digital & Technology Off |
|
|
|
|
Congress transactions
Name | Transaction date | Value |
---|---|---|
Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Robert Bresnahan | May 31, 2025 | $1.00K–$15.00K |
Julie Johnson | May 14, 2025 | $1.00K–$15.00K |
Robert Bresnahan | April 28, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Ray Dalio |
|
|
|
Sell |
Earnings Calls
Latest earnings call: April 23, 2024 (Q1 2024)